Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial


Kristensen S. L., Preiss D., Jhund P. S., Squire I., Cardoso J. S., Merkely B., ...Daha Fazla

CIRCULATION-HEART FAILURE, cilt.9, sa.1, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 1
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1161/circheartfailure.115.002560
  • Dergi Adı: CIRCULATION-HEART FAILURE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: clinical trial, diabetes mellitus, heart failure, prognosis, treatment outcome, INSULIN-RESISTANCE, HEMOGLOBIN A(1C), GLUCOSE, HOSPITALIZATION, DYSFUNCTION, INHIBITION, PREDICTOR, TOLERANCE, OUTCOMES, A1C
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Background The prevalence of pre-diabetes mellitus and its consequences in patients with heart failure and reduced ejection fraction are not known. We investigated these in the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) trial.